Keyword: South Korea Ministry of Food and Drug Safety
South Korean authorities aren’t letting Novartis off the hook easily in an ongoing bribery controversy.
Rocked by a corruption scandal in Korea, Novartis is working to strengthen and simplify its global ethics and compliance approach.
Samsung won FDA nod for a Remicade biosim, Otsuka expanded anemia deal with Akebia, analysts are cautiously optimistic about China's foreign drug proposal.
Novartis may face more furor in Korea, Astellas will develop a Prevnar rival with Affinivax, and Lilly and Chi-Med's colorectal cancer med aims for an NDA in China.
Novartis is still facing fallout from last year’s kickbacks case in South Korea. Officials there levied a set of punishments and are weighing "tougher" options, local media say.